PLUS1
Best deals to access real time data! |
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last: $ 3.79 ▲ 0.11 (2.99%) | |
| Company Name | Stock Ticker Symbol | Market | Type | ISIN | Company Description |
|---|---|---|---|---|---|
| Atossa Genetics Inc. (MM) | ATOS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.05 | -1.34% | 3.68 | 3.9772 | 3.58 | 3.66 | 3.73 | 20:00:00 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 3.76 | 3.8 | 0.04 | 1.05% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,611 | 957,750 | $ 3.7023 | $ 3.55M | 3.02M | 0.35 - 7.39 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:57 | formt | 200 | $3.79 | USD |
Atossa Genetics Inc. (MM) Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 20.78M | 5.65M | $ -8.12M | -10.92 | 0.00 | 2.62M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 0.00 | 0.00% | - | 14.20% |
Atossa Genetics Inc. (MM) News
| Date | Time | Source | News Article |
|---|---|---|---|
| 3/18/2019 | 08:30 | GlobeNewswire Inc. | Atossa Genetics Announces Receipt of $10 Million |
| 3/14/2019 | 08:30 | GlobeNewswire Inc. | Atossa Genetics Announces FDA Approval of Oral Endoxifen for.. |
| 2/08/2019 | 13:32 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) |
| 2/07/2019 | 08:30 | GlobeNewswire Inc. | Atossa Genetics Reports Results From “Expanded Access”.. |
| 2/04/2019 | 08:30 | GlobeNewswire Inc. | Atossa Genetics Provides Breast Cancer Prevention .. |
| 1/28/2019 | 08:00 | GlobeNewswire Inc. | Atossa Genetics President and CEO Dr. Steven C. Quay.. |
| 1/15/2019 | 16:12 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ATOS Price Data
| Period † | Open | High | Low | VWAP | Min Vol | Max Vol | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|---|---|
| 1 Week | 5.37 | 6.75 | 3.31 | 3.9171 | 2M | 25M | 11M | -1.69 | -31.47% |
| 1 Month | 1.47 | 7.39 | 1.29 | 5.9026 | 49k | 89M | 7M | 2.21 | 150.34% |
| 3 Months | 0.97 | 7.39 | 0.9 | 5.0655 | 17k | 89M | 3M | 2.71 | 279.38% |
| 6 Months | 1.59 | 7.39 | 0.8 | 4.5470 | 17k | 89M | 2M | 2.09 | 131.45% |
| 1 Year | 0.555 | 7.39 | 0.351 | 4.0595 | 17k | 89M | 1M | 3.125 | 563.06% |
| 3 Years | 5.25 | 7.39 | 0.22 | 2.5822 | 3k | 89M | 2M | -1.57 | -29.90% |
| 5 Years | 26.25 | 39.75 | 0.22 | 15.5340 | 3k | 327M | 4M | -22.57 | -85.98% |
Atossa Genetics Inc. (MM) Description
| Atossa Genetics Inc. is a healthcare company involved in the prevention of breast cancer through the commercialization of diagnostic medical devices and laboratory developed tests that can detect precursors to breast cancer. |
